Skip to content
TrialScanner

NCT06777433

Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases

Phase 2Active, not recruitingRADXLeadMEDPCollaborator

Registry record

Lead sponsor
Radiopharm Theranostics, Ltd
Conditions
Brain Metastases From Solid Tumors
Primary completion
Apr 23, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06777433 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06777433: Phase 2b Imaging Study of... | TrialScanner